Clinical Trials Directory

Trials / Completed

CompletedNCT03728894

Oral Sedation With and Without Nitrous Oxide

Oral Sedation With/Without Nitrous Oxide in Pediatric Dental Patients

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Tishreen University · Academic / Other
Sex
All
Age
6 Years – 9 Years
Healthy volunteers
Accepted

Summary

Aims: The objective of the current study was to evaluate the effectiveness of oral midazolam-hydroxyzine with/without nitrous oxide. Design: This was a randomized split mouth, cross over and triple-blinded clinical study. Thirty uncooperative healthy children aged six to nine, whose needed dental treatments.

Detailed description

The purpose of this study was to compare the efficacy of combining oral midazolam-hydroxyzine with/without N2O/O2 in sedating uncooperative schoolchildren undergoing dental treatment. Thirty uncooperative healthy children aged six to nine were randomly selected to receive either one tablet of oral midazolam 7.5 mg and one tablet of hydroxyzine 10 mg with 100% O2 (regimen A), or one tablet of oral midazolam 7.5 mg and one tablet of hydroxyzine 10 mg with 50% N2O/O2 (regimen B) in a crossover design. Behavior was assessed using the modified Houpt behavioral rating scale, by evaluating the videotapes of all patients at both the pretreatment phase (injection, rubber dam RD, operating high-speed handpiece with touching the tooth without drilling) and the treatment phase (drilling, restoration).

Conditions

Interventions

TypeNameDescription
DRUGMidazolam-hydroxyzine with 100% O2Patients received Oral Sedatives with 100% O2 ,Behavior was assessed using the modified Houpt behavioral rating scale, by evaluating the videotapes of all patients at both the pretreatment and treatment phases.
DRUGMidazolam-hydroxyzine with 50% N2O/O2Patients received Oral Sedatives with 50% nitrous ,Behavior was assessed using the modified Houpt behavioral rating scale, by evaluating the videotapes of all patients at both the pretreatment and treatment phases.

Timeline

Start date
2018-11-17
Primary completion
2019-01-06
Completion
2019-01-06
First posted
2018-11-02
Last updated
2019-01-08

Locations

1 site across 1 country: Syria

Source: ClinicalTrials.gov record NCT03728894. Inclusion in this directory is not an endorsement.